ArticleOncotarget2017
The oxido-metabolic driver ATF4 enhances temozolamide chemo-resistance in human gliomas.
Daishi Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
45 papers cite it
this papercites it
ArticleOncotarget2017
Daishi Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.